UnitedHealthcare is the first national health plan to partner with the California Regional Health Information Organization and agree to pay for electronic health information services statewide.

Lees meer..

The Cancer Center of Hawaii and Leeward Radiation Oncology have merged to form The Cancer Center of Hawaii Liliha and The Cancer Center of Hawaii Leeward.

Lees meer..

Initial results from three pivotal phase III trials show the Novartis investigational bronchodilator QAB149 (indacaterol) could deliver clinically relevant* lung function improvements, within five minutes of the first dose, lasting for 24 hours in patients with chronic obstructive pulmonary disease (COPD)[3],[4],[5].
Lees meer..

ISO 9001:2008 Successful Certification process coincides with HP Mile’s expanding customer base and new facility.
Lees meer..

Novartis has assumed exclusive worldwide rights to develop and commercialize QMF149, a fixed-combination of its investigational QAB149 (indacaterol) with Schering-Plough Corporation’s inhaled corticosteroid mometasone, in changes announced today to the companies’ collaboration to develop fixed-dose combination respiratory therapies.
Lees meer..

Novartis has signed a definitive agreement to acquire the specialty generic injectables business of EBEWE Pharma, providing Sandoz - the Group’s generic pharmaceuticals division - an opportunity to create a strong global platform for future growth while improving access for patients worldwide to many generic oncology medicines.
Lees meer..

Multiple sclerosis patients managed by a specialty pharmacy program were more compliant with medication, and had a lower risk of being hospitalized for their disease than those who were not managed by a specialty pharmacy program, according to a study completed by HealthCore, Inc. HealthCore researcher Jingbo Yu presented the study at the International Society of Pharmacoeconomic and Outcomes Research 14th Annual International Meeting in Orlando, Fla.
Lees meer..

Executive vice president is pharmaceutical industry veteran Arthur Simon, Ph.D. Though new in name, Palm Beach CRO - a clinical research organization recently formed in West Palm Beach, Florida - is headed by a veteran pharmacologist and clinical research executive: Arthur Simon, Ph.D.
Lees meer..

Improving communications skills and the use of a simple blood test could help cut the growing number of inappropriate prescriptions of antibiotics, a joint Cardiff University trial has discovered.
Lees meer..

A protein that helps regulate expression of androgen receptors could prove a new focal point for staging and treating testosterone-fueled prostate cancer, Medical College of Georgia researchers say. Levels of the protein, βarrestin2, are lower in some prostate cancer cells than in normal prostate cells while expression of testosterone-fed androgen receptors is higher, they report in Proceedings of the National Academy of Sciences Online Early Edition this week.
Lees meer..